Finance
Biotech company's stock soars on AIDS drug test results
Published in AIDS Weekly, May 20th, 2002
Trimeris of Durham, North Carolina, is codeveloping the drug, dubbed T-20, along with the U.S. subsidiary of the Swiss health care giant Roche Holding AG. Trimeris stock price rose $11.25 a share, or nearly 29%, to $50.50 at the close of trading April 18, 2002 on Nasdaq.
Existing AIDS drugs generally work inside cells, targeting viral enzymes involved in the replication of the virus. T-20 is the first of a new class of HIV drugs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-05-20)
More Articles from AIDS Weekly
- AIDS and HIV Pathogenesis
Cytotoxic T-lymphocyte-associated antigen contributes to CD4 cell loss - AIDS and HIV Wasting Syndrome
Reduced levels of key adipocyte protein may be trigger - AIDS and HIV Therapy
Protease inhibitors affect statin pharmacokinetics - Cytomegalovirus Retinitis
New oral medication halts blindness in AIDS patients - Kaposi Sarcoma
UNC scientist finds chief AIDS cancer needs trauma and virus to get started - Screening
Routine hospital HIV testing identifies patients with undiagnosed infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
